All Work

Jon C. Ogg

ADVENTRX Files To Raise Capital (ANX)

ADVENTRX Pharmaceuticals, Inc. (AMEX: ANX) is trading lower after a filing from Thursday evening allowing the small company to raise capital.  Yahoo! Finance shows a market cap of only $18 million, but the SEC filing…

Jon C. Ogg · 15 years ago

Canaccord Genuity Defends Green Mountain (GMCR, SBUX)

Canaccord Genuity has decided to maintain its positive position in Green Mountain Coffee Roasters Inc. (NASDAQ: GMCR).  The firm’s analyst Scott Van Winkle has maintained a Buy rating and a $94.00 target despite the move…

Jon C. Ogg · 15 years ago

Payrolls Data Positive, Overall Net-Neutral Bias on Employment

Market participants now have the awaited data from the U.S. Labor Department on February unemployment and payrolls.  The official unemployment rate came in at 8.3%. The target from Bloomberg and other sources on the…

Jon C. Ogg · 15 years ago

Green Mountain Feels Starbucks Pushback (GMCR, SBUX, KFT)

Green Mountain Coffee Roasters Inc. (NASDAQ: GMCR) was soft for most of Thursday on fears that Starbucks Corporation (NASDAQ: SBUX) was going to develop the single-serve model beyond the deal that Green Mountain has…

Jon C. Ogg · 15 years ago

Altera Guides Down Slightly (ALTR, CY)

Altera Corporation (NASDAQ: ALTR) has given its mid-quarter update and the results are somewhat of a disappointment. The company now sees guidance at a decline of 7% to 9% sequentially rather than the preliminary guidance…

Jon C. Ogg · 15 years ago

Is Sprint Really Stealing AT&T Subscribers? (S, T)

Sprint Nextel Corporation (NYSE: S) is down and out, it is losing money, and many investors question its long-term viability.  So what gives when you see a 7% gain in the share price?  Wells…

Jon C. Ogg · 15 years ago

Sangamo Presents Functional Cure For HIV/AIDS (SGMO)

Sangamo BioSciences, Inc. (NASDAQ: SGMO) has ticked higher on its report demonstrating that new clinical data is demonstrating persistent positive effects of ZFN Therapeutic as a functional cure of HIV/AIDS.  While the term ‘Cure” is…

Jon C. Ogg · 15 years ago

NBG as the Proxy for Greece (NBG)

The international markets are on pins and needles awaiting the outcome of the debt swap in Greece.  Some reports have the total coming in well over 70% participation, but there has supposedly been a…

Jon C. Ogg · 15 years ago

Second Take: Can NeurogesX Survive? (NGSX)

NeurogesX, Inc. (NASDAQ: NGSX) is seeing shares plunge after the Food & Drug Administration issued a complete response letter denying approval for the company’s Qutenza patch to assist with HIV-related pain symptoms.  Fierce Biotech noted,…

Jon C. Ogg · 15 years ago

Is Mueller’s Pipe Sale The Right Move? (MWA)

Mueller Water Products, Inc. (NYSE: MWA) is seeing its shares surge on news that it will sell its U.S. pipe business to private equity firm Wynnchurch Capital for almost $90 million plus a reimbursement…

Jon C. Ogg · 15 years ago

Fender Musical Instruments Soon To IPO… Rock On (FNDR)

Fender Musical Instruments Corporation, maker of the famed Fender guitar, is soon going to be a public company.  The maker of musical instruments filed its paperwork with the Securities and Exchange Commission for an…

Jon C. Ogg · 15 years ago